VOL. XCIV, NO. 247
★ WIDE MOAT STOCKS COMPARISON ★
NO ADVICE
Monday, December 29, 2025
Stock Comparison
Anheuser-Busch InBev SA/NV vs Novo Nordisk A/S
Compare moat strength, market structure, and segment coverage to understand how each company defends its edge.
Anheuser-Busch InBev SA/NV
ABI · Euronext Brussels
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into Anheuser-Busch InBev SA/NV's moat claims, evidence, and risks.
View ABI analysisNovo Nordisk A/S
NOVOB · Nasdaq Copenhagen
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into Novo Nordisk A/S's moat claims, evidence, and risks.
View NOVOB analysisComparison highlights
- Moat score gap: Novo Nordisk A/S leads (85 / 100 vs 75 / 100 for Anheuser-Busch InBev SA/NV).
- Segment focus: Anheuser-Busch InBev SA/NV has 6 segments (28.6% in Middle Americas); Novo Nordisk A/S has 3 segments (71.1% in Diabetes care).
- Primary market structure: Duopoly vs Oligopoly. Pricing power: Moderate vs Moderate.
- Moat breadth: Anheuser-Busch InBev SA/NV has 5 moat types across 3 domains; Novo Nordisk A/S has 5 across 3.
Primary market context
Anheuser-Busch InBev SA/NV
Middle Americas
Beer and malt-based beverages (plus growing no-alcohol and Beyond Beer)
Mexico, Central America, and Caribbean (AB InBev reporting segment)
Retailers and on-premise outlets
Brewer / brand owner + route-to-market operator
28.6%
Novo Nordisk A/S
Diabetes care
Diabetes pharmaceuticals (GLP-1 for type 2 diabetes, insulin, and related therapies)
Global
Payers/providers and patients (via wholesalers/pharmacies/hospitals)
Originator pharma (R&D, regulatory, manufacturing, commercialization)
71.1%
Side-by-side metrics
Moat coverage
Shared moat types
Anheuser-Busch InBev SA/NV strengths
Novo Nordisk A/S strengths
Segment mix
Anheuser-Busch InBev SA/NV segments
Full profile >North America
Oligopoly
Middle Americas
Duopoly
South America
Oligopoly
EMEA
Oligopoly
Asia Pacific
Competitive
Global Export & Holding Companies
Competitive
Novo Nordisk A/S segments
Full profile >Diabetes care
Oligopoly
Obesity care
Duopoly
Rare disease
Oligopoly
Want the full wide moat stocks list?
Browse the full ranking of wide moat stocks, updated with moat scores and segment context.
View the moat stocks listCuration & Accuracy
This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).
Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.